MNG97
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR6013555 | — | cohortMD2 | 0.798 |
| 2 | SRR27320680 | — | — | 0.791 |
| 3 | MNG628 | — | — | 0.771 |
| 4 | SRR4296112 | — | cohortA1 | 0.763 |
| 5 | TCGA-86-7954-01A-11R-2187-07 | — | cohortA1 | 0.762 |
| 6 | GSM6454734 | — | D | 0.747 |
| 7 | MNG1048 | — | — | 0.746 |
| 8 | SRR33532827 | — | D | 0.743 |
| 9 | TCGA-80-5611-01A-01R-1628-07 | — | cohortA4 | 0.731 |
| 10 | aMVAC.P_006_TURBT_S224 | — | — | 0.726 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 27 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.587 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.477 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.430 | Remibrutinib | — uncovered |
| ALLOGRAFT_REJECTION | 0.428 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.399 | Remibrutinib | — uncovered |
| COMPLEMENT | 0.297 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.266 | Idelalisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.231 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.221 | Inavolisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.209 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.206 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.203 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.199 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.179 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.136 | Inavolisib | — uncovered |
| HEME_METABOLISM | 0.062 | Temsirolimus | — uncovered |
| MTORC1_SIGNALING | 0.052 | Inavolisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.049 | Idelalisib | — uncovered |
| BILE_ACID_METABOLISM | 0.042 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.041 | Temsirolimus | — uncovered |